• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by WaveDancer Inc.

    8/14/24 4:08:35 PM ET
    $WAVD
    Computer Software: Prepackaged Software
    Technology
    Get the next $WAVD alert in real time by email
    NT 10-Q 1 wavd20240814_nt10q.htm FORM NT 10-Q wavd20240814_nt10q.htm

     



     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 12b-25

     

    NOTIFICATION OF LATE FILING

     

    (Check one):

    ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN

     

    ☐ Form N-CSR

     

    For Period Ended: June 30, 2024

     

    ☐ Transition Report on Form 10-K

    ☐ Transition Report on Form 20-F

    ☐ Transition Report on Form 11-K

    ☐ Transition Report on Form 10-Q

    For the Transition Period Ended:

    _____________________________________________________

     

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     


     

    PART I – REGISTRANT INFORMATION

     

    Firefly Neuroscience, Inc.
    Full Name of Registrant

     

    WaveDancer, Inc.
    Former Name if Applicable

     

    1100 Military Road
    Address of Principal Executive Office (Street and Number)

     

    Kenmore, NY 14217
    City, State and Zip Code

     



     

     

     

     

    PART II – RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

     

    (a)

    The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense

    ☒

    (b)

    The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

     

    (c)

    The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III – NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    Firefly Neuroscience, Inc., formerly known as WaveDancer, Inc. (the “Company”) is unable to complete its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Quarterly Report”), with the Securities and Exchange Commission prior to the filing deadline for the Quarterly Report without unreasonable effort and expense. On August 12, 2024, the Company consummated its previously announced reverse merger transaction (the “Merger”). Due to the timing of the Merger, the Company requires additional time to prepare the Form 10-Q.

     

    The Company expects to file the Quarterly Report within the extension period of five calendar days as provided under Rule 12b-25 under the Securities Exchange Act of 1934, as amended.

     

    PART IV – OTHER INFORMATION

     

    (1)

    Name and telephone number of person to contact in regard to this notification

     

    Jon Olsen

     

    (888)

     

    237-6412

    (Name)

     

    (Area Code)

     

    (Telephone Number)

     

    (2)

    Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

     

    Yes ☒ No ☐

       
       
       

     

    (3)

    Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

     

     

    Yes ☐ No ☒

       
       
       
       

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     

     

     

    Firefly Neuroscience, Inc.

    (Name of registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date:

    August 14, 2024

     

    By:

    /s/ Jon Olsen

         

    Name:

    Jon Olsen

         

    Title:

    Chief Executive Officer

     

    ATTENTION

    Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

     

     

     
    Get the next $WAVD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WAVD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $WAVD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Firefly Neuroscience Announces Closing of Merger Agreement and is Scheduled to Begin Trading on Nasdaq Under the Ticker Symbol 'AIFF' on August 13, 2024

      FAIRFAX, Va. and TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") technology company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders, today announced the closing of its merger transaction with WaveDancer, Inc. ("WaveDancer") (NASDAQ:WAVD). The Company is scheduled to begin trading on The Nasdaq Capital Market ("Nasdaq") under the new ticker symbol ‘AIFF' on August 13, 2024. "Brain health is a critical area of medicine that has been hindered by a lack of technological advancements needed to improve the treatme

      8/12/24 4:05:00 PM ET
      $WAVD
      Computer Software: Prepackaged Software
      Technology
    • WaveDancer Announces Reverse Stock Split

      FAIRFAX, Va., Aug. 09, 2024 (GLOBE NEWSWIRE) -- WaveDancer, Inc. (NASDAQ:WAVD) ("WaveDancer" or the "Company"), announced today that it intends to effect a reverse stock split of its common stock at a ratio of one (1) post-split share for every three (3) pre-split shares. The reverse stock split will become effective at 12:01 p.m., New York time, on Monday, August 12, 2024, and will begin trading on a split-adjusted basis when the market opens on Tuesday, August 13, 2024. The new CUSIP number for the common stock following the reverse stock split will be 317970101. Additionally, in connection with the Agreement and Plan of Merger, dated as of November 15, 2023, as amended, by and between W

      8/9/24 12:00:00 PM ET
      $WAVD
      Computer Software: Prepackaged Software
      Technology
    • Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Samer Kaba, MD as Chief Medical Officer

      FAIRFAX, Va. and TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company"), a pioneering artificial intelligence ("AI") driven company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the expansion of its leadership team with the appointment of Samer Kaba, M.D. as its Chief Medical Officer, as it nears the closing of its planned merger with WaveDancer, Inc. (NASDAQ:WAVD). "We are delighted to welcome Samer to our executive management team," said Jon Olsen, Chief Executive Officer of Firefly. "His proven track record in the neuroscience drug developme

      6/20/24 9:00:00 AM ET
      $WAVD
      Computer Software: Prepackaged Software
      Technology